Literature DB >> 19249911

New insights into mechanisms of atrial fibrillation.

B Aldhoon1, V Melenovský, P Peichl, J Kautzner.   

Abstract

Although atrial fibrillation (AF) is the most common cardiac arrhythmia in clinical practice, precise mechanisms that lead to the onset and persistence of AF have not completely been elucidated. Over the last decade, outstanding progress has been made in understanding the complex pathophysiology of AF. The key role of ectopic foci in pulmonary veins as a trigger of AF has been recognized. Furthermore, structural remodeling was identified as the main mechanism for AF persistence, confirming predominant role of atrial fibrosis. Systemic inflammatory state, oxidative stress injury, autonomic balance and neurohormonal activation were discerned as important modifiers that affect AF susceptibility. This new understanding of AF pathophysiology has led to the emergence of novel therapies. Ablative interventions, renin-angiotensin system blockade, modulation of oxidative stress and targeting tissue fibrosis represent new approaches in tackling AF. This review aims to provide a brief summary of novel insights into AF mechanisms and consequent therapeutic strategies.

Entities:  

Mesh:

Year:  2009        PMID: 19249911     DOI: 10.33549/physiolres.931651

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  29 in total

Review 1.  Atrial Fibrillation in the ICU.

Authors:  Nicholas A Bosch; Jonathan Cimini; Allan J Walkey
Journal:  Chest       Date:  2018-04-06       Impact factor: 9.410

2.  Atrial fibrillation induces myocardial fibrosis through angiotensin II type 1 receptor-specific Arkadia-mediated downregulation of Smad7.

Authors:  Xuyu He; Xiuren Gao; Longyun Peng; Shenming Wang; Yingying Zhu; Hong Ma; Jun Lin; Dayue Darrel Duan
Journal:  Circ Res       Date:  2010-12-02       Impact factor: 17.367

Review 3.  Postoperative atrial fibrillation: mechanism, prevention, and future perspective.

Authors:  Yasushige Shingu; Suguru Kubota; Satoru Wakasa; Tomonori Ooka; Tsuyoshi Tachibana; Yoshiro Matsui
Journal:  Surg Today       Date:  2012-05-23       Impact factor: 2.549

4.  The short-term associations of weather and air pollution with emergency ambulance calls for paroxysmal atrial fibrillation.

Authors:  Jone Vencloviene; Ruta Marija Babarskiene; Paulius Dobozinskas; Audrius Dedele; Kristina Lopatiene; Nijole Ragaisyte
Journal:  Environ Sci Pollut Res Int       Date:  2017-05-10       Impact factor: 4.223

Review 5.  Cryoballoon ablation of atrial fibrillation: a practical and effective approach.

Authors:  George Georgiopoulos; Dimitris Tsiachris; Antonis S Manolis
Journal:  Clin Cardiol       Date:  2016-12-19       Impact factor: 2.882

6.  Asymmetric dimethylarginine concentration and recurrence of atrial tachyarrythmias after catheter ablation in patients with persistent atrial fibrillation.

Authors:  Li Yang; Qu Xiufen; Sun Shuqin; Yu Yang; Song Ying; Yu Yanwei; Feng Wei; Yin Dechun
Journal:  J Interv Card Electrophysiol       Date:  2011-05-19       Impact factor: 1.900

7.  Oxidative stress creates a unique, CaMKII-mediated substrate for atrial fibrillation in heart failure.

Authors:  Shin Yoo; Gary Aistrup; Yohannes Shiferaw; Jason Ng; Peter J Mohler; Thomas J Hund; Trent Waugh; Suzanne Browne; Georg Gussak; Mehul Gilani; Bradley P Knight; Rod Passman; Jeffrey J Goldberger; J Andrew Wasserstrom; Rishi Arora
Journal:  JCI Insight       Date:  2018-11-02

Review 8.  Cardiac Arrhythmias in a Septic ICU Population: A Review.

Authors:  Andrei Schwartz; Evgeni Brotfain; Leonid Koyfman; Moti Klein
Journal:  J Crit Care Med (Targu Mures)       Date:  2015-11-10

9.  Severe sepsis and cardiac arrhythmias.

Authors:  Muhammad Shahreyar; Regina Fahhoum; Oluwaseun Akinseye; Sanjay Bhandari; Geetanjali Dang; Rami N Khouzam
Journal:  Ann Transl Med       Date:  2018-01

10.  Prognosis and management of new-onset atrial fibrillation in critically ill patients.

Authors:  Jun Qian; Lijun Kuang; Fei Chen; Xuebo Liu; Lin Che
Journal:  BMC Cardiovasc Disord       Date:  2021-05-05       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.